Home » Drug Delivery » Injectable Drug Markets » Subcutaneous Self Administration Markets to 2024

Subcutaneous Self Administration Markets to 2024


Subcutaneous Self Administration Markets to 2024   Subcutaneous Self Administration Markets to 2024 • Published February 2017  •  Catalog no. SQA822K17  •  Price US $3,850



Because of the ongoing need for repeat dosing posed by chronic diseases, these indications represent significant drug volume and revenue opportunities, while simultaneously challenging the industry to develop products that meet the unique needs of the non-professional caregiver. For drugs designed to be administered by the patient, therapy-specific packaging is improving adherence and treatment outcomes. In the area of delivery, subcutaneous self-administration markets is dominated by reusable injection devices designed to accept prefilled syringes or drug cartridges. These devices are improving ease-of-use and increasing the alternative device share of the growing self-injection market. Subcutaneous self-administration markets to 2024 examines in detail the drugs, devices, therapeutics and markets that are set to drive the market for subcutaneous self-administration into the next decade.

Bar_Graph Subcutaneous Self Administration Report Brochure (Download PDF)

Blue document Subcutaneous Self Administration Report Order Form (Download PDF)


Subcutaneous Self Administration Markets to 2024 – What You Will Learn

• Provides detailed analysis of self-administered subcutaneous drug products, drug delivery and device strategies, and product development factors
• Assesses key markets, market dynamics and market demographics
• Analyzes therapeutic demand drivers and evaluates SC drug products in nine key therapeutic segments
• Provides market data and forecasts to 2024
• Profiles market sector participants, their product development activities, business strategies, and corporate alliances and affiliations
• Assesses the importance of alliances and partnerships on self-administered subcutaneous drug product commercialization
• Evaluates the impact of economic, technology, and regulatory factors


Subcutaneous Self Administration Markets to 2024 – Summary of Contents

Executive Summary

Subcutaneous Self-Administration – Why it’s Growing
The Evolving Drug Pipeline
Device and Packaging Technology Advances
Shifting Patient Demographics
Healthcare Economics
Demand Drivers
Innovation in Prefilled Device Designs
Therapeutic Targets and Treatment
Competitive Landscape
Risk Factors

Subcutaneous Delivery Device Design Factors
Ergonomics and Ease of Use
Safety Features
Needle Insertion Depth
Dose Inspection/Injection Confirmation
Lyophilized Drugs/Reconstitution
High Viscosity Drugs
High Volume Drugs

Subcutaneously Delivered Drugs – Delivery Device Strategies

Handheld Devices
Autoinjectors
Pen Injectors
Prefilled Syringes
Other Handheld Devices
Wearable Devices
Patch Pumps
Large Volume Wearable Devices

Subcutaneous Self-Administration
Therapeutic Sector Product Analysis & Forecasts
Anticoagulants
Antivirals
Autoimmune Diseases
Diabetes
Hematopoietics
Hormone Replacement
Neurology
Osteoporosis
Reproductive Health

Market Factors
Regulatory Issues
DTC Marketing
Patient Education

Company Profiles


Useful Links

Self Administration and Rheumatoid Arthritis